Delivery Order 36F79720D0213-36C26222F0068
Award Date 11/4/21
Potential Completion Date 12/2/21
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Servier Pharmaceuticals LLC was awarded a $29,816.13 firm fixed price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The order is for the pharmaceutical product ONCASPAR and has a period of performance through November 30, 2020. No set-aside designation was applied to this award. Servier Pharmaceuticals LLC will deliver the ordered products to the place of...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a $39,754.84 firm fixed price delivery order to Servier Pharmaceuticals LLC of Boston, Massachusetts for the drug ONCASPAR. The contract has a period of performance through May 15, 2020 and was awarded on May 8, 2020 without a set-aside designation. Servier Pharmaceuticals LLC will provide the specified pharmaceutical to the VA network to support healthcare services for veterans in...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Genzyme Corporation, doing business as Sanofi Genzyme, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $89,094.00 order is for the delivery of various specialty pharmaceutical products, including Eliglustat (Cerdelga), Lemtrada, and Caprelsa (vandetanib), to support treatment programs for veterans. Genzyme...
- This firm fixed-price delivery order was awarded by the Department of Veterans Affairs' (VA) Veterans Health Administration (VHA) to Genzyme Corporation, doing business as Sanofi Genzyme, for the pharmaceutical product Eliglustat (Cerdelga 84mg) under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) contract. The order has a ceiling value of $246,001.38 and a performance period ending on October 26, 2023. Genzyme serves as the prime contractor, with no set-aside designation applied. This...
- The Department of Veterans Affairs Veterans Health Administration awarded a $11,882.10 delivery order against Genzyme Corporation Sanofi Genzyme Division's Pharmaceuticals and Drugs GSA Schedule contract. Under this firm fixed price order, Genzyme will provide CAPRELSA 100MG to support VHA programs. Performance will take place in Cambridge, Massachusetts over a two week period in November and December 2023. The award utilizes Genzyme's GSA Pharmaceuticals and Drugs Schedule, a multiple award...
- Genzyme Corporation, operating through its Sanofi Genzyme division and Genzyme Therapeutics business unit, has been awarded a $17,830.87 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) prime vendor contract vehicle. The order is for the drug eliglustat to be delivered to the Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 located in Cambridge, Massachusetts by March 17, 2020. The delivery order is a firm fixed...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,793.52 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract to supply SIGNIFOR LAR 30 MG. The prime contractor, Recordati Rare Diseases Inc., will deliver the specified pharmaceutical to the VA facility located in Bartlett, Tennessee. The order has a period of performance from December 27, 2023 through December 29, 2023 and utilizes a firm fixed price contract type....
- This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 to Horizon Therapeutics USA Inc. for the provision of pegolticase, a drug used to treat gout, with a potential value of $16,558.72. The order has a firm fixed price and period of performance through March 31, 2022 to support the VA's healthcare programs serving veterans in the Lake...
- The Department of Veterans Affairs Veterans Health Administration awarded a $21,746.58 delivery order against Recordati Rare Diseases Inc.'s GSA Schedule contract for the pharmaceutical products SIGNIFOR LAR 20 & 40 MG. The prime contractor Recordati Rare Diseases Inc. will provide the drugs to VA facilities located in Bartlett, Tennessee over a two day period from December 12-14, 2023. The contract was awarded under Recordati's Pharmaceuticals and Drugs GSA Schedule, a multiple award IDIQ...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,868 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule to procure pasireotide 40 mg for its Veterans Integrated Service Network 5. The firm fixed price order runs from September 29 to October 3, 2023 and will be performed in Bartlett, Tennessee by Recordati Rare Diseases, Inc. Division. As the prime contractor, Recordati Rare Diseases will supply the specialty pharmaceutical...